Association between early detection of soluble TNF-receptors and mortality in burn patients

被引:10
|
作者
Ribeiro, CA
Andrade, C
Polanczyk, CA
Clausell, N
机构
[1] Univ Fed Rio Grande Sul, Hosp Clin Porto Alegre, Div Cardiol, BR-90003500 Porto Alegre, RS, Brazil
[2] Hosp Municipal Pronto Socorro, Intens Care Unit, Porto Alegre, RS, Brazil
关键词
burns; inflammation; TNF-receptors; mortality; prognosis;
D O I
10.1007/s00134-001-1190-5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To describe early sequential profiling of circulating levels of tumor necrosis factor alpha (TNF-alpha), TNF-1 and TNF-2 soluble receptors (sTNFR1 and sTNFR2), and of endothelin (ET-1) in patients with severe burn injury, and its association with mortality. Design: Prospective study. Setting: Intensive Care Burn Unit at a community hospital. Patients: Twenty patients with total burn surface area (TBSA)greater than or equal to30%. Interventions: None. Measurements and results: Patients were enrolled within 6 h from the injury. Blood samples were drawn at zero, 6, 12, and 24 h for sequential ELISA measurement of plasma marker levels. Data are expressed as mean+/-SD. Age, TBSA, and inhalation injury were not significantly different between survivors (n=9; 30+/-13 years, TBSA 40+/-12%) and nonsurvivors (n=11, 38+/-15 years, TBSA 56+/-20%). sTNFR1 levels were increased in nonsurvivors (2937+/-1676 pg/ml; 4548+/-1436 pg/ml) as compared to survivors (1313+/-561 pg/ml; 2561 804 pg/ml) at 6 h and 24 h, respectively (P=0.01 and 0.002). sTNFR2 levels were significantly increased in nonsurvivors (4617+/-1,876 pg/ml vs 2611+/-1,326 pg/ml) only at 6 h (P=0.015). TNF-alpha and ET-1 levels were not different between nonsurvivors and survivors. After adjustment for TBSA, sTNFR1 and sTNFR2 remained significantly higher in nonsurvivors. Conclusion: Early and progressive increase in sTNFR1 and sTNFR2 levels is associated with higher risk for poor outcome in severely burned patients.
引用
收藏
页码:472 / 478
页数:7
相关论文
共 50 条
  • [1] Association between early detection of soluble TNF-receptors and mortality in burn patients
    C. Ribeiro
    C. Andrade
    C. Polanczyk
    N. Clausell
    Intensive Care Medicine, 2002, 28 : 472 - 478
  • [2] THE PRESENCE OF TNF AND SOLUBLE TNF-RECEPTORS IN OBSTRUCTIVE-JAUNDICE
    BEMELMANS, MHA
    BUURMAN, WA
    GOUMA, DJ
    GASTROENTEROLOGY, 1993, 104 (04) : A665 - A665
  • [3] EVIDENCE FOR DIFFERENT EFFECTS OF SOLUBLE TNF-RECEPTORS ON VARIOUS TNF MEASUREMENTS IN HUMAN BIOLOGICAL-FLUIDS
    ENGELBERTS, I
    STEPHENS, S
    FRANCOT, GJM
    VANDERLINDEN, CJ
    BUURMAN, WA
    LANCET, 1991, 338 (8765): : 515 - 516
  • [4] Soluble receptors of tumor necrosis factor-α: early predictors of mortality in patients with severe burn injury
    CA Ribeiro
    L Tarso
    GR Busnello
    S Alves
    C Andrade
    N Clausell
    Critical Care, 5 (Suppl 3):
  • [5] Lack of soluble TNF-receptors in women with recurrent spontaneous abortion and possibility for its correction
    Chernyshov, VP
    Vodyanik, MA
    Pisareva, SP
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2005, 54 (05) : 284 - 291
  • [6] Soluble TNF receptors as prognostic factors for mortality
    Parks, RW
    Gardiner, KR
    Halliday, MI
    Rowlands, BJ
    GUT, 1997, 40 (04) : 560 - 560
  • [7] Soluble TNF-receptors, naive CD31+ T cells and B-1a cells in psoriatic patients
    Chernyshov, PV
    Vodyanik, MA
    Kolyadenko, VG
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2005, 19 (06) : 775 - 776
  • [8] TNF-ALPHA AND SOLUBLE TNF-RECEPTORS IN STABLE AND INFECTIOUS CAPS - LOCAL SYNTHESIS ONLY PRESENT DURING PERITONITIS
    ZEMEL, D
    DEWAART, DR
    STRUIJK, DG
    KREDIET, RT
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 486 - 486
  • [9] TNF-RECEPTORS IN PATIENTS WITH HCV-REINFECTION AFTER LIVER-TRANSPLANTATION
    ARNOLD, JC
    HEILIG, B
    KALLINOWSKI, B
    OTTO, G
    KOMMERELL, B
    THEILMANN, L
    GASTROENTEROLOGY, 1994, 106 (04) : A860 - A860
  • [10] Enzyme therapy improved remission time, soluble TNF-receptors and β2-microglobulin concentration in chemotherapy treated multiple myeloma patients
    Sakalova, A
    Desser, L
    Zavadova, E
    Holomanova, D
    Mohr, T
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 353 - 353